MidLantic Urology is a clinical research site located in Bala-Cynwyd, Pennsylvania, United States 19004.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
MidLantic Urology has participated in 38 clinical trials with 23 currently active.
Therapeutic areas: Prostate Cancer, High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma.
Sponsors: Invitae Corporation, Angle plc, Janssen Pharmaceutica N.V., Belgium.
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MidLantic Urology has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MidLantic Urology has 38 clinical trials on record, with 23 currently active. Their work covers Prostate Cancer, High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma.
MidLantic Urology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.